Risk Assessment of BRONJ in Oncologic Patients Treated with Bisphosphonates: Follow-Up to 18 Months
Joint Authors
Orsini, G.
Sparabombe, Scilla
Vitali, Lucia
Nori, Alessandra
Berlin, Ricarda Sara
Mazur, Marta
Putignano, Angelo
Source
International Journal of Dentistry
Issue
Vol. 2014, Issue 2014 (31 Dec. 2014), pp.1-7, 7 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2014-09-01
Country of Publication
Egypt
No. of Pages
7
Main Subjects
Abstract EN
Objectives.
Bisphosphonates related osteonecrosis of the jaw (BRONJ) is a pathological condition characterized by bone exposure or latent infection in patients treated with the drug.
The aim of the study is to monitor the BRONJ level of risk health in patients with cancer, according to a preventive clinical protocol, which is firstly aimed at reducing risk factors such as the periodontal infections.
Materials and Methods.
10 patients participated in the protocol and were evaluated at baseline and after 3 and 18 months of treatment with bisphosphonates, through full mouth plaque and bleeding scores (FMPS and FMBS), clinical attachment level (CAL) measurement, and the occurrence of osteonecrosis.
Results.
The mean plaque and bleeding were reduced and the CAL has not shown significant changes and in no cases was there manifestation of BRONJ.
Conclusion.
The protocol proved crucial for the maintenance of good oral health conditions by eliminating the risk of BRONJ during the observation period.
American Psychological Association (APA)
Sparabombe, Scilla& Vitali, Lucia& Nori, Alessandra& Berlin, Ricarda Sara& Mazur, Marta& Orsini, G.…[et al.]. 2014. Risk Assessment of BRONJ in Oncologic Patients Treated with Bisphosphonates: Follow-Up to 18 Months. International Journal of Dentistry،Vol. 2014, no. 2014, pp.1-7.
https://search.emarefa.net/detail/BIM-1036380
Modern Language Association (MLA)
Sparabombe, Scilla…[et al.]. Risk Assessment of BRONJ in Oncologic Patients Treated with Bisphosphonates: Follow-Up to 18 Months. International Journal of Dentistry No. 2014 (2014), pp.1-7.
https://search.emarefa.net/detail/BIM-1036380
American Medical Association (AMA)
Sparabombe, Scilla& Vitali, Lucia& Nori, Alessandra& Berlin, Ricarda Sara& Mazur, Marta& Orsini, G.…[et al.]. Risk Assessment of BRONJ in Oncologic Patients Treated with Bisphosphonates: Follow-Up to 18 Months. International Journal of Dentistry. 2014. Vol. 2014, no. 2014, pp.1-7.
https://search.emarefa.net/detail/BIM-1036380
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1036380